Immuron (IMRN) Liabilities and Shareholders Equity (2016 - 2025)

Immuron has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $100926.2 in Q3 2025.

• For the quarter ending Q3 2025, Liabilities and Shareholders Equity fell 35.1% year-over-year to $100926.2; the trailing twelve-month figure through Sep 2025 stood at $14.7 million (down 41.06% YoY), and the FY2025 full-year result was $100926.2, down 35.1% from the prior year.
• Liabilities and Shareholders Equity for Q3 2025 stood at $100926.2, down from $6.5 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $17.3 million in Q3 2022, with the low at $100926.2 in Q3 2025.
• Average Liabilities and Shareholders Equity over 5 years is $6.3 million, with a median of $3.4 million recorded in 2025.
• Year-over-year, Liabilities and Shareholders Equity surged 6335.21% in 2022 and sank 99.21% in 2023.
• Tracing IMRN's Liabilities and Shareholders Equity over 5 years: stood at $253772.8 in 2021, then jumped by 6335.21% to $16.3 million in 2022, then sank by 99.21% to $129434.6 in 2023, then soared by 6048.66% to $8.0 million in 2024, then slumped by 98.73% to $100926.2 in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $100926.2 (Q3 2025), $6.5 million (Q2 2025), and $8.0 million (Q4 2024), per Business Quant data.

Peer Comparison